Ideogen AG

Swiss Biotech Association

Member

IDEOGEN Group is a family owned Swiss pharmaceutical group, providing global access to specialty medicines for unmet medical needs. We specialize in the commercialization of specialty medicines in Europe with challenging and evolving healthcare dynamics.

Products, services, technology

AZACITIDIN, BICNU, CLOFARA, FOSCARNET Ideogen, MELPHALAN Ideogen, SIDOVIS, TREOSUL,TRIOGEN

https://ideogen.com
+41 43 311 52 52
Info@ideogen.com
Murat Goeker, murat.goker@ideogen.com

Location

Hurdnerstrasse 119, 8640 Hurden, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2013
Number of employees in Switzerland

10-19

Key business

Core competencies

You may also be interested in

InkVivo Technologies AG

InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricated novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).
Lugano

Member

Qiáo Advisors GmbH

We offer bespoke consulting to biotechs and investors, increasing the value of innovations by accelerating and broadening patient access. 桥 (qiáo) means “bridge” in Mandarin. Our vision is to enable a seamless healthcare system for the benefit of patients, by building bridges between stakeholders.
4153 Reinach

Member

Delta Medical Promotions AG

Delta Medical offers its partners an expedited pathway to enter international markets, including Russia, Ukraine, and Eurasia via our 700 skilled professionals across ten affiliates. Our services include registering biotech medicines in all our markets, negotiating pricing and market access issues.
8001 Zürich

Member